Singulair generic
Singulair is one of the best medicines that can prevent and treat asthma attack symptoms in adults as well as children who are 12 months and older. It can also be used as a treatment for runny and blocked nose, sneezing etc; that are triggered due to allergies in adults and children who are six months or older. Singulair generic is not available as of now, and the ones that are being advertised on the Internet are cheap imitations which are illegal and fake. Singulair is a patented medication whose patency will expire on August 3, 2012.
Singulair is manufactured by Merck & Co and the patent which the manufacturer holds prevents any generic version to be manufactured in the US. Once the first patent will expire on August 3, 2012, Singulair generic will become available. Though August 2012 is being touted as the earlier possible time by which the generic version can become available, it is not a certain thing because circumstances may crop up which may extend this date. This can include other patents for Singulair uses and other associated lawsuits. Once the patent expires legally, other companies get the right to make generic versions of Singulair.
Singulair is used to treat and manage asthma, prevent asthma triggered by exercise and provide relief from hayfever symptoms. Singulair is referred by its generic name ‘Montelukast’ but the latter is not actually Singulair generic. There is a difference between generic name and generic version when it comes to a medicine. The active ingredient of any medicine, in this case Montelukast, is referred to as the ‘generic name’. However for the generic version of the medicine to be released, the original patent should expire setting the ball rolling for other companies besides the original manufacturer, to legally manufacture the product.